Louisville, KYNCT00682032Now EnrollingIRB Ready

Non Small Cell Lung Cancer Clinical Trial in Louisville, KY

Access cutting-edge non small cell lung cancer treatment through this clinical trial at a research site in Louisville. Study-provided care at no cost to qualified participants.

Sponsored by University of Louisville

Quick Self-Assessment

See if you qualify for this Louisville location

Preparing your pre-screening questions…

Expert Care in Louisville

Access non small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non small cell lung cancer treatment provided free

Apply for This Louisville Location

Check if you qualify for this non small cell lung cancer clinical trial in Louisville, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Louisville

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Louisville site if eligible
  4. 4Begin participation

About This Non Small Cell Lung Cancer Study in Louisville

The purpose of this study is to determine how beta-glucan affects the immune system in subjects with non-small cell lung cancer.

Sponsor: University of Louisville

Who Can Participate

Inclusion Criteria

suspected or definitive diagnosis of non-small cell lung cancer (NSCLC)
treatment naive or no treatment within 6 months prior to enrollment
able to swallow pills
Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3
absolute neutrophil count (ANC) at least 1500/microl
able to understand and willing to sign a written informed consent document

Exclusion Criteria

history of hypersensitivity reactions attributed to beta-glucan
currently receiving continuous corticosteroids or other ongoing immunosuppressive therapy
presence of an uncontrolled intercurrent illness including but not limited to: ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements AIM 3: Inclusion Criteria:
resectable non-small cell lung cancer (NSCLC), as determined by a thoracic surgeon
treatment naive
able to swallow pills
Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
must be an operative candidate
absolute neutrophil count (ANC) at least 1500/microl
able to understand and willing to sign a written informed consent document Exclusion Criteria:
history of hypersensitivity reactions attributed to beta-glucan
currently receiving continuous corticosteroids or other ongoing immunosuppressive therapy
presence of an uncontrolled intercurrent illness including but not limited to: ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Louisville?

Yes, this clinical trial (NCT00682032) has an active research site in Louisville, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non Small Cell Lung Cancer Treatment Options in Louisville, KY

If you're searching for non small cell lung cancer treatment options in Louisville, KY, this clinical trial (NCT00682032) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Louisville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Louisville, KY

See all lung cancer clinical trials recruiting in Louisville — not just this study.

Browse Lung Cancer Trials in Louisville →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Louisville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Louisville, KY